Middle East and Africa Immunosuppressant Drugs Market 2019-2028

MARKET OUTLOOK

This report on the immunosuppressant drugs market in the Middle East and Africa states that the market is expected to grow with a CAGR of 5.59% in the forecast period 2019-2028. South Africa, Saudi Arabia, Turkey, the UAE, and Rest of MEA together form the market in this region.
In South Africa, close to 4300 people are awaiting a cornea or a life-saving organ transplant. However, only 0,2% of the country’s total population has registered for organ donation. South Africa is also known to have one of the highest cases of renal failure in the African region. At present, there are more than 5000 patients with end-stage renal failure, and 2500 of them are waiting for a renal transplant. Transplantation is not only cost-effective, but it also provides a better quality of life to these patients, as compared to undergoing dialysis. Therefore, there is a huge demand for kidney transplant procedures in South Africa.

These procedures are not only limited to kidney transplants, but also for liver. This procedure is also increasingly being performed in recent years. In the Western Cape, liver transplants take place at Red Cross Children’s Hospital and Groote Schuur Hospital. Whereas, heart transplantation is performed at centers in Cape Town and Johannesburg. Lung transplantation is also being increasingly performed. All these factors are helping the growth of the South African immunosuppressant drugs market.

COMPETITIVE OUTLOOK

The prominent companies in this market are Intas Pharmaceuticals Ltd (Accord Healthcare), Novartis AG, F Hoffmann-La Roche Ltd, Pfizer Inc, Cipla Ltd, Astellas Pharma Inc, Dr Reddys Laboratories Ltd, and Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc).

1. Middle East and Africa Immunosuppressant Drugs Market - Summary

2. Industry Outlook

2.1. Market Definition
2.2. Key Insights
2.2.1. Organ Transplantation Leads the Market by End-User
2.2.2. Pharmaceutical Industry Showing Growth Trends
2.2.3. Impact of Covid-19 on Transplant Recipients
2.3. Evolution & Transition of Immunosuppressant Drugs
2.4. Porters Five Force Analysis
2.4.1. Threat of New Entrants
2.4.2. Threat of Substitute
2.4.3. Bargaining Power of Suppliers
2.4.4. Bargaining Power of Buyers
2.4.5. Threat of Competitive Rivalry
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Market Drivers
2.7.1. Demand from Organ Transplantation
2.7.2. Rise in the Number of Autoimmune Disorders
2.8. Market Restraints
2.8.1. Side Effects of Immunosuppressant Drugs
2.9. Market Opportunities
2.9.1. Demand from Emerging Economies
2.9.2. Exports of Drugs and Medicine Worldwide on Rise
2.10. Market Challenges
2.10.1. Lack of Awareness About Organ Donation

3. Middle East and Africa Immunosuppressant Drugs Market Outlook – by Drug Class

3.1. Corticosteroids
3.2. Monoclonal Antibodies
3.3. Calcineurin Inhibitors
3.4. Mtor Inhibitors
3.5. Others

4. Middle East and Africa Immunosuppressant Drugs Market Outlook - by Distribution Channel

4.1. Hospital Pharmacies
4.2. Retail Pharmacies
4.3. Online Pharmacies

5. Middle East and Africa Immunosuppressant Drugs Market Outlook - by End-User

5.1. Organ Transplantation
5.2. Autoimmune Disorders
5.3. Others

6. Middle East and Africa Immunosuppressant Drugs Market – Regional Outlook

6.1. United Arab Emirates
6.2. Turkey
6.3. Saudi Arabia
6.4. South Africa
6.5. Rest of Middle East & Africa

7. Competitive Landscape

7.1. Abbvie Inc
7.2. Allergan (Acquired by Abbvie Inc)
7.3. Astellas Pharma Inc
7.4. Bristol-Myers Squibb Company
7.5. Cipla Ltd
7.6. Dr Reddys Laboratories Ltd
7.7. F Hoffmann-La Roche Ltd
7.8. GlaxoSmithKline plc
7.9. Intas Pharmaceuticals Ltd (Accord Healthcare)
7.10. Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
7.11. Mylan Nv
7.12. Novartis AG
7.13. Pfizer Inc
7.14. Sanofi
7.15. Veloxis Pharmaceuticals Inc

8. Methodology & Scope

8.1. Research Scope
8.2. Sources of Data
8.3. Research Methodology

List of Tables

Table 1: Middle East and Africa Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)
Table 2: Market Attractiveness Index
Table 3: Vendor Scorecard
Table 4: Side-Effects of Immunosuppressant Drugs
Table 5: Top 15 Positive Net Exports Countries and Negative Net Exports for Drugs & Medicines Countries
Table 6: Middle East and Africa Immunosuppressant Drugs Market, by Drug Class, 2019-2028 (In $ Million)
Table 7: Middle East and Africa Immunosuppressant Drugs Market, by Distribution Channel, 2019-2028 (In $ Million)
Table 8: Middle East and Africa Immunosuppressant Drugs Market, by End-User, 2019-2028 (In $ Million)
Table 9: Middle East and Africa Immunosuppressant Drugs Market, by Country, 2019-2028 (In $ Million)

List of Figures

Figure 1: Evolution & Transition of Immunosuppressant Drugs
Figure 2: Porter's Five Force Analysis
Figure 3: Middle East and Africa Immunosuppressant Drugs Market, by Corticosteroids, 2019-2028 (In $ Million)
Figure 4: Middle East and Africa Immunosuppressant Drugs Market, by Monoclonal Antibodies, 2019-2028 (In $ Million)
Figure 5: Middle East and Africa Immunosuppressant Drugs Market, by Calcineurin Inhibitors, 2019-2028 (In $ Million)
Figure 6: Middle East and Africa Immunosuppressant Drugs Market, by Mtor Inhibitors, 2019-2028 (In $ Million)
Figure 7: Middle East and Africa Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 8: Middle East and Africa Immunosuppressant Drugs Market, by Hospital Pharmacies, 2019-2028 (In $ Million)
Figure 9: Middle East and Africa Immunosuppressant Drugs Market, by Retail Pharmacies, 2019-2028 (In $ Million)
Figure 10: Middle East and Africa Immunosuppressant Drugs Market, by Online Pharmacies, 2019-2028 (In $ Million)
Figure 11: Middle East and Africa Immunosuppressant Drugs Market, by Organ Transplantation, 2019-2028 (In $ Million)
Figure 12: Middle East and Africa Immunosuppressant Drugs Market, by Autoimmune Disorders, 2019-2028 (In $ Million)
Figure 13: Middle East and Africa Immunosuppressant Drugs Market, by Others, 2019-2028 (In $ Million)
Figure 14: Middle East and Africa Immunosuppressant Drugs Market, Regional Outlook, 2019 & 2028 (In %)
Figure 15: United Arab Emirates Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 16: Turkey Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 17: Saudi Arabia Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 18: South Africa Immunosuppressant Drugs Market, 2019-2028 (In $ Million)
Figure 19: Rest of Middle East & Africa Immunosuppressant Drugs Market, 2019-2028 (In $ Million)